Ignite Creation Date:
2024-05-06 @ 7:37 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06072508
Status:
RECRUITING
Last Update Posted:
2023-10-10
First Post:
2023-10-03
Brief Title:
Prognostic Interest of Vasorin in Septic Shock
Sponsor:
Centre Hospitalier Universitaire Amiens
Organization:
Centre Hospitalier Universitaire Amiens
Study Overview
Official Title:
Prognostic Interest of Vasorin in Septic Shock
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VASO-SHOCK
Brief Summary:
In septic shock the intensity and duration of low blood pressure can lead to a critical reduction in renal tissue perfusion and lead to the onset of more or less severe Acute Kidney Injury AKI Vasorin Vasn is a protein strongly expressed in large vessels and kidneys whose functions are still poorly known Previous experimental studies show that Vasn is associated with decreased Angiotensin II concentrations a vessel contractility defect and early mortality
The investigators hypothesize that Vasn the potential direct regulator of blood pressure would be an early biomarker predicting the severity of AKI post septic shock which may be associated with mortality from septic shock or lead to longer-term Chronic Renal Failure CKD
The investigators hypothesize that Vasn the potential direct regulator of blood pressure would be an early biomarker predicting the severity of AKI post septic shock which may be associated with mortality from septic shock or lead to longer-term Chronic Renal Failure CKD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None